Hello!

I'm currently working with liposomes encapsulation,but many things have been going wrong. At the moment, I'm trying to encapsulate BSA and Ascorbic Acid (AA) as models compounds in order to optimize the encapsulation efficiency (EE) and to better understand how the process works. However, up until now, have not been satisfactory.

I'm using thehin film hydration method followed by probe sonication. Although I’ve read several papers suggesting that this may not be the best method for achieving high EE, I decided to use it due to equipment availability. I also tested the extrusion method.

To measure the protein EE, I used Bradford assay, but the absorvance (abs) were unreliable. It always showed a higher abs than the initial solution (like the protein concentration was increased after the probe sonication/extrusion). The readings consistently showed higher absorbance than the initial solution, as if the protein concentration had increased after probe sonication or extrusion. For AA, I used UV absorbance at 265 nm. Regardless of the technique, the molecule, or other experimental conditions, the results have not been promising. I'm not entirely sure what I’m doing wrong.

One of the main problems I’m facing is separating the free molecules from the encapsulated ones. After extensive testing, nothing seems to work. I tried increasing centrifugation speed and time, even ultracentrifugation, but it made no difference. The Bradford assay still showed turbidity due to lipids in the supernatant, and UV measurements also revealed a lipid-related peak. In addition, DLS measurements confirmed the presence of particles in the supernatant, indicating that liposomal structures or aggregates were still present after centrifugation. Given that HPLC is currently not an option, what alternative approaches could I use both for separation and for accurate measurement of encapsulation efficiency?

Another issue I’m dealing with involves the concentrations of lipids, BSA, and AA. I'm not sure whether the amount of liposomes formed is sufficient to encapsulate the entire amount of the active compound. I think this could be impacting the encapsulation efficiency. Is there a recommended lipid-to-drug or lipid-to-protein ratio for these types of systems that I could follow as a starting point?

Thank you!

More Thalita Martins Senra's questions See All
Similar questions and discussions